Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             244 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A ‘case-control’ estimate of the relative risk of venous thrombosis in patients with familial protein C deficiency 1991
61 S1 p. 54-
1 p.
artikel
2 Accelerated hepatitis B vaccination schedule in hemophiliacs 1991
61 S1 p. 5-
1 p.
artikel
3 Accuracy of real time B-mode ultrasonography in the diagnosis of deep vein thrombosis in hip surgery 1991
61 S1 p. 70-
1 p.
artikel
4 A combination of dipyridamole with low-dose aspirin in the treatment of unstable angina. A multicenter pilot study 1991
61 S1 p. 38-
1 p.
artikel
5 Acquired factor XIII deficiency 1991
61 S1 p. 110-
1 p.
artikel
6 Activation of coagulation during hemodialysis with high biocompatibility membranes without heparin 1991
61 S1 p. 100-
1 p.
artikel
7 Activation of platelet function ex vivo and in vivo in diabetic patients 1991
61 S1 p. 21-
1 p.
artikel
8 Administration of Hyate:C induces specific antibody formation against porcine von Willebrand factor 1991
61 S1 p. 9-
1 p.
artikel
9 Administration of purified eicosapentaenoic:docosahxaenoic acid to healthy volunteers: Influence on lipids and on blood circulating cells 1991
61 S1 p. 49-
1 p.
artikel
10 Adverse effects of treatment with porcine factor VIII (pFVIII) 1991
61 S1 p. 8-
1 p.
artikel
11 A monoclonal antibody which specifically inhibits the anti-heparin activity of human and rabbit PF4 1991
61 S1 p. 45-
1 p.
artikel
12 Anagrelide: A new drug for therapeutical use in essential thrombocyhemia (ET) Ferrari, A.
1991
61 S1 p. 29-
1 p.
artikel
13 A new APTT reagent activated with micronized silica: First multicenter validation 1991
61 S1 p. 113-
1 p.
artikel
14 A new case of dysfibrinogenemia: Fibrinogen pontedera La Gioia, A.
1991
61 S1 p. 111-
1 p.
artikel
15 A new membrane for dialysis reportedly not requiring heparin: Effects on blood clotting and platelet function 1991
61 S1 p. 100-
1 p.
artikel
16 An improved method for leukocyte filtration with the St. George's filtrometer 1991
61 S1 p. 103-
1 p.
artikel
17 Anticoagulant and fibrinolytic pharmacokinetics of sulodexide in man Barbanti, M.
1991
61 S1 p. 62-
1 p.
artikel
18 Anti-D immunoglobulin for treatment of immune thrombocytopenic purpura (ITP): Comparison between HIV-related ITP and idiopahic ITP 1991
61 S1 p. 74-
1 p.
artikel
19 Anti-fibrin monoclonal antibody for in vivo immunoscintigraphic detection of thrombi Di Loreto, M.
1991
61 S1 p. 38-
1 p.
artikel
20 Antiphospholipid antibodies in juvenile venous thromboembolism 1991
61 S1 p. 56-
1 p.
artikel
21 Antiphospholipid syndrome (APS) in juvenile ischemic stroke: Retrospective study Ettorre, C.
1991
61 S1 p. 80-
1 p.
artikel
22 Antiplatelet activity of dipyridamole in cyclooxygenase independent platelet aggregation Pratico, D.
1991
61 S1 p. 107-
1 p.
artikel
23 Antiplatelet drugs for primary prevention trials: Evaluation of their hemorrhagic potential 1991
61 S1 p. 58-
1 p.
artikel
24 Antithrombotic activity and apparent thrombolytic properties of DESMIN 370, a new low molecular weight dermatan sulphate Barbanti, M.
1991
61 S1 p. 61-
1 p.
artikel
25 An unbalance between thrombin and plasmin activity in vivo is present in hypothyroidism 1991
61 S1 p. 24-
1 p.
artikel
26 Apparent autosomal recessive inheritance in patients with type II a von Willebrand disease 1991
61 S1 p. 16-
1 p.
artikel
27 A prothrombin time-based assay of protein S (PS) 1991
61 S1 p. 85-
1 p.
artikel
28 A radioreceptor assay for platelet-derived growth factor (PDGF): Application to PDGF release from platelets and monocytes 1991
61 S1 p. 86-
1 p.
artikel
29 A randomized double blind placebo controlled trial of MF 701 dermatan sulphate for prevention of deep vein thrombosis (DVT) in hip fracture 1991
61 S1 p. 94-
1 p.
artikel
30 Arterial thrombosis associated with protein C congenital deficiency 1991
61 S1 p. 84-
1 p.
artikel
31 ASA antiaggregating effect is only partial in conditions in which a clotting activation occurs 1991
61 S1 p. 108-
1 p.
artikel
32 Aspirin but not ticlopidine inhibits PAI-1 antigen release by human platelets 1991
61 S1 p. 108-
1 p.
artikel
33 Assignment of the reference values to a calibration plasma house standard 1991
61 S1 p. 114-
1 p.
artikel
34 Atherogenic lipoproteins regulate PAI-1 release by endothelial cells Camera, M.
1991
61 S1 p. 18-
1 p.
artikel
35 Author index 1991
61 S1 p. 123-130
8 p.
artikel
36 Behaviour of lupus anticoagulant and PAI_1 activity in young patients affected from ischemic stroke Ferro, D.
1991
61 S1 p. 47-
1 p.
artikel
37 Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin 1991
61 S1 p. 57-
1 p.
artikel
38 Binding of certain dyes to VWF through different sites 1991
61 S1 p. 14-
1 p.
artikel
39 Biological and clinical evaluation of intranasal DDAVP 1991
61 S1 p. 17-
1 p.
artikel
40 Bleeding time (BT), blood groups and von Willebrand Factor (VWF) in normal subjects: Influence of intraplatelet vWF on BT 1991
61 S1 p. 15-
1 p.
artikel
41 Calcitonin, calcium ions and erythrocyte deformability in neoplastic patients 1991
61 S1 p. 75-
1 p.
artikel
42 Calcium-heparin therapy in patients with chronic obstructive pulmonary disease 1991
61 S1 p. 43-
1 p.
artikel
43 Carrier detection and prenatal diagnosis of hemophilia A 1991
61 S1 p. 13-
1 p.
artikel
44 Central retinal vein thrombosis as first manifestation of plasma cell dyscrasias 1991
61 S1 p. 39-
1 p.
artikel
45 Characterization of anti phospholipid antibody (APA) specificities in systemic lupus erythematosus (SLE) 1991
61 S1 p. 65-
1 p.
artikel
46 Characterization of a panel of monoclonal antibodies to von Willebrand Factor (vWF) and their use in a sensitive ELISA technique Colibretti, M.L.
1991
61 S1 p. 16-
1 p.
artikel
47 Characterization of von Willebrand factor in cultured human endothelial cells from patients with different types of von Willebrand disease 1991
61 S1 p. 14-
1 p.
artikel
48 Chronic hypertransaminasemia in multitransfused hemophiliacs: Role of different blood-borne viruses 1991
61 S1 p. 7-
1 p.
artikel
49 cis - and trans -RuCl2 (DMSO)4 reduce the tumor-associated fibrinolytic activity in 3LL-bearing mice 1991
61 S1 p. 117-
1 p.
artikel
50 Clinical and laboratory aspects in 80 subjects with antiphospholipid syndrome (APS) Schiavoni, M.
1991
61 S1 p. 68-
1 p.
artikel
51 Cloricromene (AD6) reduces platelet (PLT) response in the presence of polymorphonuclear leucocytes (PMN) 1991
61 S1 p. 92-
1 p.
artikel
52 Cloricromene distribution in human platelets and its pharmacological effects 1991
61 S1 p. 109-
1 p.
artikel
53 Coagulation inhibitors (PC e AT III) in newborns of the gestosic mothers 1991
61 S1 p. 83-
1 p.
artikel
54 Colloidal silica clotting time (CSCT) in the detection of lupus anticoagulant 1991
61 S1 p. 80-
1 p.
artikel
55 Combined use of strain-gauge plethysmography and plasma D-dimer (DD) determination in clinically suspected deep venous thrombosis (DVT) 1991
61 S1 p. 71-
1 p.
artikel
56 Comparison between Born's optical method in PRP and electronic method in whole blood in the study of “in vitro” platelet hyperhypofunction 1991
61 S1 p. 46-
1 p.
artikel
57 Comparison of computerized impedance plethysmography. (CIP), standardized doppler ultrasound (SDU) and real-time compression ultrasonography (CUS) with contrast venography in the diagnosis of deep-venous thrombosis (DVT) in symptomatic outpatients 1991
61 S1 p. 53-
1 p.
artikel
58 Complement, contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency) 1991
61 S1 p. 19-
1 p.
artikel
59 Computer assisted prescription of oral anticoagulants 1991
61 S1 p. 97-
1 p.
artikel
60 Congenital deficiency of antithrombin III, protein C, protein S: Analysis of 80 cases 1991
61 S1 p. 55-
1 p.
artikel
61 Contemporary deficiency of vitamin K-dependents procoagulants and anticoagulants (PC) in late hemorrhagic disease of newborn 1991
61 S1 p. 84-
1 p.
artikel
62 Coumarin resistance and lung cancer 1991
61 S1 p. 31-
1 p.
artikel
63 Cyclic GMP inhibits human platelet aggregation and exocitosis evoked by protein kinase C activators 1991
61 S1 p. 106-
1 p.
artikel
64 Cysteine proteinases as a procoagulant in acute leukemias and a proaggregating factor in TTP 1991
61 S1 p. 116-
1 p.
artikel
65 DDAVP does not increase factor VIII (FVIII) plasma levels in patients with severe von Willebrand Disease (vWD) treated with cryoprecipitate 1991
61 S1 p. 17-
1 p.
artikel
66 Defibrotide inhibits leukotriene B4 production by neutrophils after oral administration in man 1991
61 S1 p. 87-
1 p.
artikel
67 Defibrotide use in haemodialysis 1991
61 S1 p. 112-
1 p.
artikel
68 Dermatan sulfate (DS) vs heparin (H) in treatment of disseminated intravascular coagulation (DIC) in acute leukemia (AL) 1991
61 S1 p. 32-
1 p.
artikel
69 Desmin 370, a low molecular weight dermatan sulphate: Pharmacokinetic studies in the dog Rita Milani, M.
1991
61 S1 p. 40-
1 p.
artikel
70 Detection of “active” atherosclerotic lesions in human carotid arteries in vivo by combined scintigraphy with 111-In-labelled platelets and 99-m-Tc-red blood cells 1991
61 S1 p. 52-
1 p.
artikel
71 Determination of fibrin degradation products by ELISA 1991
61 S1 p. 33-
1 p.
artikel
72 Differential detection of recombinant single chain urokinase-type plasminogen activator (rec.scu-PA) from its two chain derivative (rec.tcu-PA) in plasma 1991
61 S1 p. 34-
1 p.
artikel
73 Different sensitivity to thrombosis of four coagulation tests detecting lupus anticoagulant (LA) in patients affected from systemic lupus erythematosus (SLE) Saliola, M.
1991
61 S1 p. 66-
1 p.
artikel
74 D-indobufen totally accounts for platelet-inhibitory effects of D-L indobufen 1991
61 S1 p. 92-
1 p.
artikel
75 Dose-requirements for inhibition of neutrophil aggregation by glucocorticoids: Relevance to therapeutic effects 1991
61 S1 p. 51-
1 p.
artikel
76 Dysfunctional protein C (PC) with a faster migrating component on SDS-PAGE 1991
61 S1 p. 53-
1 p.
artikel
77 Effectiveness of high-doses I.V. IG in a case of thrombotic thrombocytopenic purpura (TIP) 1991
61 S1 p. 74-
1 p.
artikel
78 Effect of aspirin on tissue plasminogen activator release in perfused rat hindlegs 1991
61 S1 p. 33-
1 p.
artikel
79 Effect of dermatan sulfate MF 701 (DS) on the hemostatic and fibrinolytic parameters of healthy volunteers: A randomized, placebo controlled clinical study 1991
61 S1 p. 63-
1 p.
artikel
80 Effect of fibrinogen concentration on the velocity of platelet aggregation 1991
61 S1 p. 44-
1 p.
artikel
81 Effect of heparin treatment on fibrinolytic and coagulative systems after streptokinase therapy in acute myocardial infarction 1991
61 S1 p. 28-
1 p.
artikel
82 Effect of protons and chloride on the amidase activity in human α-thrombin De Cristofaro, R.
1991
61 S1 p. 114-
1 p.
artikel
83 Effects of dipyridamole and quercetin on the metabolism of arachidonic acid via lipoxygenase during platelet-neutrophil interactions 1991
61 S1 p. 120-
1 p.
artikel
84 Effects of fibrinolytic and clotting tests of a new ascites-apheresis system in liver cirrhosis patients 1991
61 S1 p. 101-
1 p.
artikel
85 Effects of porcine von Willebrand factor on human platelets 1991
61 S1 p. 8-
1 p.
artikel
86 Effects on haemostasis after administration of recombinant erythropoietin to patients affected by chronic uremia 1991
61 S1 p. 112-
1 p.
artikel
87 Efficacy of plasma exchange in the treatment of a case of post-transfusion thrombocytopenic purpura (PTP) 1991
61 S1 p. 73-
1 p.
artikel
88 Efficacy of ticlopidine in preventing thromboembolic episodes in patients with VVI pacemaker 1991
61 S1 p. 57-
1 p.
artikel
89 Efficiency of defibrotide in prophylaxis of post surgical deep venous thrombosis (DVT) 1991
61 S1 p. 40-
1 p.
artikel
90 Elevation of thrombin-antithrombin complexes (TAT) during thrombolytic therapy in patients with myocardial infarction 1991
61 S1 p. 26-
1 p.
artikel
91 Endothelin levels in patients with isolated Raynaud phenomenon 1991
61 S1 p. 105-
1 p.
artikel
92 Evaluation of a low molecular weight dermatan sulfate (DS) in the prevention of experimental thrombosis 1991
61 S1 p. 61-
1 p.
artikel
93 Evaluation of bleeding and bleeding time by analysis of bleeding time curves: The effect of aspirin and nitroglycerin 1991
61 S1 p. 107-
1 p.
artikel
94 Evaluation of intra- and post-operative tolerability of the LMWH CY 216 in neoplastic patients 1991
61 S1 p. 64-
1 p.
artikel
95 Evaluation of intra- and post-operative tolerability of the LMWH CY 215 with reference to sex and age 1991
61 S1 p. 64-
1 p.
artikel
96 Evaluation of mt-Pa thrombolytic activity by radioimaging techniques Di Loreto, M.
1991
61 S1 p. 25-
1 p.
artikel
97 Evaluation of new methods for protein C and protein S detection using monoclonal antibodies Tombesi, S.
1991
61 S1 p. 78-
1 p.
artikel
98 Evaluation of PC/PS system in patients with antiphospholipid antibodies Brancaccio, V.
1991
61 S1 p. 48-
1 p.
artikel
99 Evaluation of some haemorheological parameters in patients with acute cerebrovascular disease 1991
61 S1 p. 103-
1 p.
artikel
100 Evidence for a key role of hyperglycemia - dependent antithrombin III alterations in the coagulation abnormalities of diabetes mellitus 1991
61 S1 p. 24-
1 p.
artikel
101 Ex vivo effect of subcutaneously administered unfractioned heparin and LMWH CY 216 on LP(a) levels for prophylaxis of DVT Milani, M.
1991
61 S1 p. 106-
1 p.
artikel
102 Factor VIII inhibitor in post-partum treatment with high-dose intravenous immunoglobulin 1991
61 S1 p. 68-
1 p.
artikel
103 Feasibility of prenatal diagnosis of hemophilia B by amplification of Mn1I polimorphic site 1991
61 S1 p. 13-
1 p.
artikel
104 Fibrinogen, FPA, BB 15–42 in hyperthyroidism before and after treatment 1991
61 S1 p. 23-
1 p.
artikel
105 Fibrinolysis and lysis of plasma proteins induced by tissue plasminogen activator (rt PA) in patients with pulmonary embolism 1991
61 S1 p. 29-
1 p.
artikel
106 Generation of At-Pa/fibrin bispecific monoclonalantibody Anastasi, A.M.
1991
61 S1 p. 25-
1 p.
artikel
107 G.I.S.S.I. 2: Evaluation of haemostasis modifications induced by thrombolytic therapy 1991
61 S1 p. 26-
1 p.
artikel
108 Haemostasis evaluation during autologus bone marrow infusion 1991
61 S1 p. 77-
1 p.
artikel
109 Hemorheologic changes in uremic patients under chronic hemodialysis treated with recombinant human erythropoietin (rhEPO) 1991
61 S1 p. 99-
1 p.
artikel
110 Hemostatic parameters and iopamidol: In vitro interactions and ex vivo changes after I.V. Administration for urography 1991
61 S1 p. 113-
1 p.
artikel
111 Heparin binding to and internalization by human monocytes Modesti, PA
1991
61 S1 p. 50-
1 p.
artikel
112 Heterogenous expression of antiphospholipid antibodies during pregnancy Luise, F.
1991
61 S1 p. 82-
1 p.
artikel
113 Heterogenous expression of antiphospholipid antibodies syndrome Brancaccio, V.
1991
61 S1 p. 67-
1 p.
artikel
114 High factor VIII (F VIII) values may simulate a protein C deficiency (PC) 1991
61 S1 p. 79-
1 p.
artikel
115 High incidence of myeloproliferative disorder as underlying disease in young patients with splanchnic venous thrombosis 1991
61 S1 p. 69-
1 p.
artikel
116 High prevalence of anti-HCV antibodies in a cohort of hemophiliacs from Apulia region: Low risk in patients treated with virus inactivated FVIII concentrates Schiavoni, M.
1991
61 S1 p. 5-
1 p.
artikel
117 HLA antigens and HIV status in hemophilia 1991
61 S1 p. 2-
1 p.
artikel
118 Human pharmacokinetics and pharmacodynamics of MF 701 dermatan sulphate administered by continuous intravenous infusion 1991
61 S1 p. 63-
1 p.
artikel
119 Human prostacyclin platelet receptors and platelet lipidic composition in diabetes mellitus Modesti, PA
1991
61 S1 p. 22-
1 p.
artikel
120 Hyperpigmentation of the skin and of the nails possibly related to azidothymidine (AZT) treatment 1991
61 S1 p. 3-
1 p.
artikel
121 Immunolocalization of coagulation factor XIII (FXIII) in cultured human endothelial cells 1991
61 S1 p. 121-
1 p.
artikel
122 Immunological status in HIV positive patients with severe hemophilia a treated with plasma derived mAb purified FVIII concentrate 1991
61 S1 p. 2-
1 p.
artikel
123 Impaired leukotriene B4 (LTB4) production by polymorphonuclear cells (PMNs) in cirrhosis (C): Possible role of defective cell-cell interactions 1991
61 S1 p. 86-
1 p.
artikel
124 Impedance plethysmography in the diagnosis of asymptomatic deep vein thrombosis in hip surgery: A venography controlled study 1991
61 S1 p. 70-
1 p.
artikel
125 Increased thromboxane biosynthesis in polycythemia vera Landolfi, R.
1991
61 S1 p. 116-
1 p.
artikel
126 Increased TxB generation in pseudomenopause induced by the GnRH analogue buserelin 1991
61 S1 p. 21-
1 p.
artikel
127 Increased von Willebrand Factor degradation after thrombolysis in patients with acute myocardial infarction and bleeding complications 1991
61 S1 p. 89-
1 p.
artikel
128 Increase of fibrinogen and plasma viscosity in healthy elderly subjects 1991
61 S1 p. 102-
1 p.
artikel
129 Influence of oral defibrotide administration on fibrinolytic system in atherosclerotic patients Quintarelli, C.
1991
61 S1 p. 104-
1 p.
artikel
130 Influence of population characteristics on aspirin anti-platelet effects Melandri, G.
1991
61 S1 p. 59-
1 p.
artikel
131 Inhibition by iloprost of platelet activation induced by stimulated polymorphonuclear leukocytes (PMN) 1991
61 S1 p. 50-
1 p.
artikel
132 Interleukin - 1 stimulates a phospholipase C active on PC, but not on polyphosphoinositides in human monocytes 1991
61 S1 p. 122-
1 p.
artikel
133 Intrafamiliar spread of hepatitis C virus (HCV) in hemophiliacs and von Willebrand patients 1991
61 S1 p. 6-
1 p.
artikel
134 Intraperitoneal insulin therapy modulates in vivo thrombin activity in insulin-dependent (type I) diabetics 1991
61 S1 p. 22-
1 p.
artikel
135 In vitro effects of five calcium channel blockers on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation Rostagno, C.
1991
61 S1 p. 93-
1 p.
artikel
136 “In vitro” research model to study streptokinase platelet damage 1991
61 S1 p. 89-
1 p.
artikel
137 Is it useful to combine low dose aspirin with n-3PUFA supplementation? Studies on the fibrinolytic response to venous occlusion 1991
61 S1 p. 19-
1 p.
artikel
138 Isolation of a plasmatic factor interacting with anticardiolipin antibodies: its identification as β2glycoprotein I 1991
61 S1 p. 65-
1 p.
artikel
139 Italian registry of patients with antiphospholipid antibodies: Survey and proposal 1991
61 S1 p. 46-
1 p.
artikel
140 Laboratory and clinical quality of oral anticoagulant therapy (OAT) before and after computer assistance 1991
61 S1 p. 97-
1 p.
artikel
141 LMWH CY216 versus UFH in preventing venous thromboembolism in elective major surgery: Preliminary results 1991
61 S1 p. 72-
1 p.
artikel
142 Locoregional r-TPA treatment in acute arterial thromboembolism 1991
61 S1 p. 36-
1 p.
artikel
143 Long-term sequelae of deep-vein thrombosis 1991
61 S1 p. 95-
1 p.
artikel
144 Lp(a) and fibrinolysis in dyslipidemic patients - Preliminary data Catalano, M.
1991
61 S1 p. 88-
1 p.
artikel
145 Lupus anticoagulant (LA): Its relevance in ATP and in thrombotic syndrome 1991
61 S1 p. 47-
1 p.
artikel
146 Lupus anticoagulant preceded by factor VIII inhibitor Luise, F.
1991
61 S1 p. 81-
1 p.
artikel
147 MF 701 dermatan sulfate for prevention of deep vein thrombosis (DVT) after general surgery 1991
61 S1 p. 95-
1 p.
artikel
148 Microcirculation changes in dialyzed patients receiving erythropoietin (EPO) treatment for anemia 1991
61 S1 p. 98-
1 p.
artikel
149 Modulation of the procoagulant-fibrinolytic balance of blood mononuclear cells by two retinoids 1991
61 S1 p. 87-
1 p.
artikel
150 Molecular analysis of the plasminogen gene in a family with type I plasminogen deficiency 1991
61 S1 p. 54-
1 p.
artikel
151 Monoclonal immunoglobulin with heparin like activity during plasma cell leukemia: Biochemical and functional characterization 1991
61 S1 p. 48-
1 p.
artikel
152 Negative relationship between protein C and free T3 in hyperthyroidism 1991
61 S1 p. 83-
1 p.
artikel
153 Nephelometric measurement of plasma fibrinogen with ACL in patients on stabilized anticoabulant treatment: Effect of thromboplastins and within-patient variability of fibrinogen levels 1991
61 S1 p. 98-
1 p.
artikel
154 New protocol for the administration of urokinase in the treatment of acute pulmonary embolism: Our experiences 1991
61 S1 p. 36-
1 p.
artikel
155 Non radioactive technique for molecular diagnosis of hemophilia A 1991
61 S1 p. 12-
1 p.
artikel
156 No psychiatric disorders in hemophiliacs HIV+ 1991
61 S1 p. 4-
1 p.
artikel
157 Org 10172 as a thromboprophilactic agent in patients undergoing transvesical prostatectomy. A dose finding study 1991
61 S1 p. 94-
1 p.
artikel
158 Orthotopic liver transplantation (OLTX) in post nechrotic cirrhosis (PNC): Intraoperative management of coagulation disturbancies 1991
61 S1 p. 102-
1 p.
artikel
159 Outcome of hip surgery patients with lower limb-negative venography at discharge 1991
61 S1 p. 69-
1 p.
artikel
160 Oxigen radical production and antioxidant enzymatic systems in human platelets affected with essential thrombocythemia 1991
61 S1 p. 90-
1 p.
artikel
161 PCR and specific oligonucleotide hybridization for the molecular characterization and carrier detection of hemophilia A 1991
61 S1 p. 11-
1 p.
artikel
162 Peripheral vascular disease multicenter clinical study: Ticlopidine vs picotamide - preliminary results 1991
61 S1 p. 56-
1 p.
artikel
163 Pharmacokinetics of a placental factor XIII concentrate in homozygous factor XIII deficiency 1991
61 S1 p. 11-
1 p.
artikel
164 Picotamide can inhibit the internalization of a TxA2 analogue by human platelets Modesti, PA
1991
61 S1 p. 93-
1 p.
artikel
165 Plasma beta-endorphin, ACTH and cortisol levels in HIV infected haemophiliacs 1991
61 S1 p. 3-
1 p.
artikel
166 Platelet adhesion and aggregation: New concepts and old theories 1991
61 S1 p. 90-
1 p.
artikel
167 Platelet radiolabelling with 111-In-oxine and 111-In-tropolone: Optimization and comparison of the techniques 1991
61 S1 p. 45-
1 p.
artikel
168 Platelets function and fibrinolysis during physical effort Ferri, G.M.
1991
61 S1 p. 37-
1 p.
artikel
169 Platelet stimulation induced by activated polymorphonuclear leukocytes 1991
61 S1 p. 49-
1 p.
artikel
170 Platelet thromboxane B2 in the laboratory differential diagnosis of primary versus secondary thrombocytosis 1991
61 S1 p. 30-
1 p.
artikel
171 Platelet-von Willebrand Factor (vWF) in myelodysplastic syndromes (MDS) 1991
61 S1 p. 76-
1 p.
artikel
172 Potent anti-thrombotic effect of Albolabrin, a disintegrin with RGD sequence isolated from viper venom 1991
61 S1 p. 41-
1 p.
artikel
173 Potentiation of dermatan sulfate by small amounts of unfractionated heparin (UFH) 1991
61 S1 p. 62-
1 p.
artikel
174 Preface Abbate, R.
1991
61 S1 p. v-
1 p.
artikel
175 Preliminary characterization of a panel of monoclonal antibodies to human factor VII Coppola, R.
1991
61 S1 p. 115-
1 p.
artikel
176 Preliminary results of a randomized therapeutical protocol for ATP 1991
61 S1 p. 73-
1 p.
artikel
177 Preliminary retrospective pharmacokinetic study on 6 severe hemophiliacs A with inhibitor treated with porcine factor VIII (Hyate:C) Lattarulo, M.
1991
61 S1 p. 10-
1 p.
artikel
178 Prevention of arterial occlusion in the rabbit carotid artery by heparin and low molecular weight heparins 1991
61 S1 p. 41-
1 p.
artikel
179 Prevention of deep vein thrombosis by mechanical methods 1991
61 S1 p. 42-
1 p.
artikel
180 Prevention of postoperative isotopic deep vein thrombosis by low molecular weight heparin (CY 216): A randomized study in cancer patients udergoing abdominal surgery 1991
61 S1 p. 72-
1 p.
artikel
181 Prognostic value of HIV-1 isolation from peripheral blood mononuclear cells: A study in a group of apulian hemophiliacs 1991
61 S1 p. 1-
1 p.
artikel
182 Prophylaxis with defibrotide of venous thrombosis after gynaecological surgery: A controlled study versus calcium heparin 1991
61 S1 p. 71-
1 p.
artikel
183 Prostaglandin E2 (PGE2) potentiates platelet aggregation by a mechanism independent from cytoplasmic calcium movements and possibly related to the activation of protein kinase C (PKC) 1991
61 S1 p. 44-
1 p.
artikel
184 Protein C and protein S anticoagulant activity in acute versus chronic cardiac ischemic syndromes: Relationship to factor IX and to markers of in vivo thrombin activity Vigano'D'Angelo, S.
1991
61 S1 p. 20-
1 p.
artikel
185 Protein C deficiency in two children with cerebral thrombosis 1991
61 S1 p. 77-
1 p.
artikel
186 Protein composition in resting and activated platelets of patients affected with essential thrombocythemia 1991
61 S1 p. 75-
1 p.
artikel
187 Protein C (PC) and protein S (PS) levels in chronic uremic patients before and after dialysis 1991
61 S1 p. 82-
1 p.
artikel
188 Protein C (PC) clotting assay performed with an highly automated coagulometer 1991
61 S1 p. 79-
1 p.
artikel
189 Protein S activity in patients with heredofamilial protein S deficiency and in patients with venous thrombosis. Results of a new functional method 1991
61 S1 p. 85-
1 p.
artikel
190 Protein S in patients with antiphospholipid antibodies syndrome Rossi, E.
1991
61 S1 p. 67-
1 p.
artikel
191 Psychological study of HIV+ haemophilic subjects De Giglio, F.
1991
61 S1 p. 4-
1 p.
artikel
192 PUROFIL: a new factor VIII concentrate Borri, M.G.
1991
61 S1 p. 9-
1 p.
artikel
193 Recurrent deep venous thrombosis: Means of prevention 1991
61 S1 p. 42-
1 p.
artikel
194 Reduced intra-platelet level of 12-HETE and abnormal platelet adhesion in essential thrombocythemia 1991
61 S1 p. 115-
1 p.
artikel
195 Reduced platelet adhesion after ticlopidine administration in patients with polycythemia vera (PV) 1991
61 S1 p. 58-
1 p.
artikel
196 Reduced platelet adhesion to umbical artery subendothelium from a neonate with von Willebrand's Disease (vWD) 1991
61 S1 p. 15-
1 p.
artikel
197 Reduced urinary fibrinolytic activity in glomerulonephritis: Relationship with the severity of the disease 1991
61 S1 p. 35-
1 p.
artikel
198 Regulation of intraplatelet ionized Ca2+ by lipid A 1991
61 S1 p. 110-
1 p.
artikel
199 Regulation of thromboxane A2 (TxA2) receptors on human platelets (Plts) by TxA2-receptor (TR) antagonists 1991
61 S1 p. 118-
1 p.
artikel
200 Relationship between androgenic activity, insulin and plasminogen activator inhibitor type 1 (PAI-1) in premenopausal women with abdominal obesity 1991
61 S1 p. 23-
1 p.
artikel
201 Relationship between FVII and thrombin release 1991
61 S1 p. 96-
1 p.
artikel
202 Relationship between HCV infection, liver damage and imbalance of lymphocyte subpopulations in a cohort of hemophiliacs Gambatesa, V.
1991
61 S1 p. 6-
1 p.
artikel
203 Risk of subsequent malignant neoplasms in patients with deep-vein thrombosis 1991
61 S1 p. 39-
1 p.
artikel
204 Role of heparin and related compounds on the proliferation of smooth muscle cells of the arterial wall 1991
61 S1 p. 51-
1 p.
artikel
205 rtPA treatment of Budd-Chiari syndrome during thrombocytemia 1991
61 S1 p. 27-
1 p.
artikel
206 Simultaneous study of ATP release, calcium movements and platelet aggregation with and without extracellular calcium 1991
61 S1 p. 119-
1 p.
artikel
207 Solid phase immunoaffinity purification of anticardiolipin antibodies Pengo, V.
1991
61 S1 p. 66-
1 p.
artikel
208 Stimulating effect of plasma on peripheral blood momonuclear cells procoagulant activity 1991
61 S1 p. 121-
1 p.
artikel
209 Stimulation of platelet aggregation by H202 Pratico', D.
1991
61 S1 p. 43-
1 p.
artikel
210 Stimulation of platelets by fluoroaluminate (AlF4 −): Evidence for the involvement of a G-protein in phospholipase (PL) A2 activation 1991
61 S1 p. 119-
1 p.
artikel
211 Study of HLA system and detection of lymphocytic p 24 Ag antigen and of HIV infective virus in HIV-seropositive and HIV-seronegative politransfused hemophiliacs 1991
61 S1 p. 1-
1 p.
artikel
212 Study of the activation parameters for hemostasis in children with nephotic syndrome 1991
61 S1 p. 101-
1 p.
artikel
213 Subject index 1991
61 S1 p. 131-134
4 p.
artikel
214 Supranormal multimers of von Willebrand factor in cancer patients following high-dose chemoradiotherapy for autologous bone marrow transplantation 1991
61 S1 p. 76-
1 p.
artikel
215 The comparative effect of recombinant hirudin and standard heparin on improving t-PA induced thrombolysis in rabbits 1991
61 S1 p. 60-
1 p.
artikel
216 The doctor-patient relationship in hemophilia: The effect of HIV infection Pasqual Marsettin, E.
1991
61 S1 p. 18-
1 p.
artikel
217 The effect of hyperadrenergic states on platelet responsiveness to adrenaline: The role of leukocytes 1991
61 S1 p. 20-
1 p.
artikel
218 The fenton-type OHo generating reaction activates human platelets Iuliano, L.
1991
61 S1 p. 122-
1 p.
artikel
219 The functional and structural defect of Fibrinogen Naples 1991
61 S1 p. 55-
1 p.
artikel
220 The hypothesis of phospholipase inhibition by glucocorticoids: An evaluation in vivo in cells from peripheral blood and from inflammatory tissues 1991
61 S1 p. 120-
1 p.
artikel
221 The infusion of intralipid causes a reduction in the plasma levels of t-PA 1991
61 S1 p. 34-
1 p.
artikel
222 The plasma levels of tissue-type plasminogen activator (t-PA) in breast cancer Coviello, M.
1991
61 S1 p. 31-
1 p.
artikel
223 The treatment of hemophiliacs with inhibitor: 8 years experience in the hemophilia centre of Bari Ciavarella, N.
1991
61 S1 p. 7-
1 p.
artikel
224 The usefulness of antiplatelet agents in the prevention of fluorouracil (5-FU) cardiotoxicity Andriani, A.
1991
61 S1 p. 109-
1 p.
artikel
225 Thrombin and plasmin activities in vivo are increased in psoriasis 1991
61 S1 p. 105-
1 p.
artikel
226 Thrombin-antithrombin III (TAT) complexes and factor VII (F VII) for the detection of hemostatic system activation 1991
61 S1 p. 96-
1 p.
artikel
227 Thrombin generation is not increased in the blood of hemophilia B patients after a purified factor IX concentrate 1991
61 S1 p. 10-
1 p.
artikel
228 Thrombocytopathia in patients with antiphospholipid antibodies (APA) 1991
61 S1 p. 52-
1 p.
artikel
229 Thrombolyic treatment of splanchnic vein thrombosis with tissue plasminogen activator 1991
61 S1 p. 28-
1 p.
artikel
230 Thrombolytic activity of chimeric recombinant plasminogen activators in rabbits 1991
61 S1 p. 60-
1 p.
artikel
231 Thrombomodulin potentiates the degradation of recombinant single-chain urokinase plasminogen activator (rec.scu-PA, FCE 26177) by thrombin ‘in vitro” 1991
61 S1 p. 59-
1 p.
artikel
232 Thrombotic risk in adult all: Study of coagulation factors and physiological inhibitors 1991
61 S1 p. 30-
1 p.
artikel
233 Ticlopidine facilitates the deaggregation of human platelets aggregated by thrombin 1991
61 S1 p. 91-
1 p.
artikel
234 Ticlopidine selectively inhibits the responses of human platelets to ADP 1991
61 S1 p. 91-
1 p.
artikel
235 Tissue plasminogen activator and urokinase: A randomized study in acute myocardial infarction 1991
61 S1 p. 27-
1 p.
artikel
236 Tissue plasminogen activator (t-PA) and PAI-1 in breast cancer 1991
61 S1 p. 117-
1 p.
artikel
237 t-PA, u-PA and total euglobulin fibrinolytic activity during orthotopic liver transplantation 1991
61 S1 p. 88-
1 p.
artikel
238 Transient lupus type anticoagulant in a three year old girl Amendola, G.
1991
61 S1 p. 81-
1 p.
artikel
239 Tumor necrosis factor production by peripheral monocytes from head and neck cancer patients 1991
61 S1 p. 32-
1 p.
artikel
240 Unfractionated heparin (UH) and a low molecular weight heparin (LMWH-fragmin) in paired hemodialysis hemofiltration (PFD) 1991
61 S1 p. 99-
1 p.
artikel
241 Urokinase and ATIII treatment in thrombosis during nephrotic syndrome 1991
61 S1 p. 37-
1 p.
artikel
242 Use of purified dermatan sulphate for heparin cofactor II (HC-II) assay 1991
61 S1 p. 78-
1 p.
artikel
243 Von Willebrand Factor degradation in 20 patients with acquired clinical conditions characterized by systemic proteolysis 1991
61 S1 p. 111-
1 p.
artikel
244 Weak agonists and platelet cytoplasmatic alkalynization. Effect of aggregation, thromboxane A2 (TxA2) and concentration of external Ca2+[Ca2+o] 1991
61 S1 p. 118-
1 p.
artikel
                             244 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland